ERINN FINCHER: Open Payments
NPI 1811575798 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 12 payments from 8 companies in 2025. Trend: 2023 $1,118 · 2024 $429 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: JARDIANCE, Kerendia, Rybelsus, Ozempic, GEMTESA, EDARBI, ZORYVE, FARXIGA.
Industry payments across GA — which companies pay providers there.
